首页 > 最新文献

Journal of obesity and weight loss therapy最新文献

英文 中文
Obesity, diabetes and metabolic syndrome in terms of preventive medicine and healthcare 预防医学和保健方面的肥胖、糖尿病和代谢综合征
Pub Date : 2015-09-03 DOI: 10.4172/2165-7904.S1.013
Y. Ozturk
{"title":"Obesity, diabetes and metabolic syndrome in terms of preventive medicine and healthcare","authors":"Y. Ozturk","doi":"10.4172/2165-7904.S1.013","DOIUrl":"https://doi.org/10.4172/2165-7904.S1.013","url":null,"abstract":"","PeriodicalId":243288,"journal":{"name":"Journal of obesity and weight loss therapy","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129947218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Obesity Indicators and Chronic Illness among Chinese Americans: A Pilot Study 美籍华人肥胖指标与慢性疾病:一项初步研究
Pub Date : 2015-08-31 DOI: 10.4172/2165-7904.1000270
Shan Liu, M. Fu, Sophia H. Hu, Vincent Y. Wang, R. Crupi, Jeanna M. Qiu, C. Cleland, G. Melkus
Background: Chinese Americans have increased rates for obesity in the United States. Little is known about obesity indicators and chronic illness, and the relationship between them in Chinese Americans. Methods: A descriptive and cross-sectional study was designed. Chinese-American adults were recruited from a community health center in New York. Obesity indicators including waist circumference (WC), hip circumference (HC), Body Mass Index (BMI), weight to hip ratio, weight to height ratio, fasting blood glucose (FPG), Glycated hemoglobin (HbA1C) were evaluated. Chronic illnesses were assessed using a researcher developed self-report checklist and verified by medical record review. Results: Among 162 Chinese American participants, who were recruited, 94 subjects had fewer than three chronic illnesses and 68 subjects had three or more chronic illnesses. The three most common chronic illnesses in this population were diabetes (65.4%), hypertension (46.9%), and eye problem (38.3%). Controlling for all demographic factors, numbers of chronic illnesses remained significant associations with obesity indicators of WC (p=0.006), HC (p=0.020), weight to height ratio (p=0.011), HbA1C (p=0.026). Obesity indicators also had significant associations with individual chronic illness of diabetes, hypertension, heart diseases, eye and food problems. Conclusion: General Obesity indicator (BMI), central obesity indicators (WC, HC, weight to height ratio) and HbA1c were significantly associated with chronic illnesses in Chinese Americans.
背景:美籍华人在美国的肥胖率有所上升。我们对华裔美国人的肥胖指标与慢性疾病的关系知之甚少。方法:设计描述性和横断面研究。研究人员从纽约的一家社区健康中心招募了华裔美国成年人。评估腰围(WC)、臀围(HC)、体重指数(BMI)、体重臀围比、体重身高比、空腹血糖(FPG)、糖化血红蛋白(HbA1C)等肥胖指标。使用研究者开发的自我报告检查表对慢性疾病进行评估,并通过医疗记录审查进行验证。结果:在招募的162名美籍华人参与者中,94名受试者患有三种以下慢性疾病,68名受试者患有三种或三种以上慢性疾病。这一人群中最常见的三种慢性疾病是糖尿病(65.4%)、高血压(46.9%)和眼疾(38.3%)。在控制所有人口统计学因素后,慢性疾病数量与肥胖指标WC (p=0.006)、HC (p=0.020)、体重与身高比(p=0.011)、糖化血红蛋白(p=0.026)仍有显著相关性。肥胖指标还与糖尿病、高血压、心脏病、眼睛和食物问题等个别慢性疾病有显著关联。结论:一般肥胖指标(BMI)、中心肥胖指标(WC、HC、体重与身高比)和HbA1c与华裔美国人慢性疾病有显著相关性。
{"title":"Obesity Indicators and Chronic Illness among Chinese Americans: A Pilot Study","authors":"Shan Liu, M. Fu, Sophia H. Hu, Vincent Y. Wang, R. Crupi, Jeanna M. Qiu, C. Cleland, G. Melkus","doi":"10.4172/2165-7904.1000270","DOIUrl":"https://doi.org/10.4172/2165-7904.1000270","url":null,"abstract":"Background: Chinese Americans have increased rates for obesity in the United States. Little is known about obesity indicators and chronic illness, and the relationship between them in Chinese Americans. \u0000Methods: A descriptive and cross-sectional study was designed. Chinese-American adults were recruited from a community health center in New York. Obesity indicators including waist circumference (WC), hip circumference (HC), Body Mass Index (BMI), weight to hip ratio, weight to height ratio, fasting blood glucose (FPG), Glycated hemoglobin (HbA1C) were evaluated. Chronic illnesses were assessed using a researcher developed self-report checklist and verified by medical record review. \u0000Results: Among 162 Chinese American participants, who were recruited, 94 subjects had fewer than three chronic illnesses and 68 subjects had three or more chronic illnesses. The three most common chronic illnesses in this population were diabetes (65.4%), hypertension (46.9%), and eye problem (38.3%). Controlling for all demographic factors, numbers of chronic illnesses remained significant associations with obesity indicators of WC (p=0.006), HC (p=0.020), weight to height ratio (p=0.011), HbA1C (p=0.026). Obesity indicators also had significant associations with individual chronic illness of diabetes, hypertension, heart diseases, eye and food problems. \u0000Conclusion: General Obesity indicator (BMI), central obesity indicators (WC, HC, weight to height ratio) and HbA1c were significantly associated with chronic illnesses in Chinese Americans.","PeriodicalId":243288,"journal":{"name":"Journal of obesity and weight loss therapy","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114398373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Relationship of Pre-Operative Stress Level to Sustained Outcome in Gastric Bypass Surgery 胃分流术中术前应激水平与持续预后的关系
Pub Date : 2015-08-31 DOI: 10.4172/2165-7904.1000269
R. Lanyon, B. Maxwell
Purpose: Previous research has shown that pre-operative health status can serve as a moderator in enhancing the accuracy of certain variables for predicting sustained weight loss after gastric bypass surgery. The present study investigated the role of pre-operative stress level as a moderator in identifying useful pre-operative predictors of sustained weight loss. Materials and Methods: Follow-up data at a mean of 3.2 years post-operatively were available for 111 patients who had undergone pre-operative assessment on 227 variables including four psychological assessment instruments. These measures were studied for their success in predicting sustained weight loss separately for patients who were under low and high pre-operative stress. Results: As anticipated, several types of variables (support, coping skills, good adjustment, and good cognitive functioning) predicted success for both groups. In addition, for low-stress patients, social drinking and self-efficacy variables (strong expectations of a broad range of positive changes), and a broader range of personal support variables were the best predictors. For high-stress patients, the best predictors included the presence of a troubled intimate relationship, lack of attention to personal health matters, an active history of smoking, and the possible need for psychiatric medication. Overall, the results show some consistency with the basic postulates of selfdetermination theory. Conclusion: The findings provide further support for the view that the investigation of pre-intervention variables can provide useful information in enhancing the predictive accuracy of the success of major life interventions in medical and other settings.
目的:以往的研究表明,术前健康状况可以作为一个调节因素,提高某些变量预测胃分流术后持续体重减轻的准确性。本研究调查了术前应激水平在确定有用的术前持续体重减轻预测因子中的调节作用。材料与方法:对111例患者进行术前评估,包括4项心理评估工具在内的227项变量,平均术后3.2年随访。研究人员分别对术前应激水平低和应激水平高的患者成功预测持续体重减轻进行了研究。结果:正如预期的那样,几种类型的变量(支持、应对技能、良好的适应能力和良好的认知功能)预测了两组的成功。此外,对于低压力患者,社交饮酒和自我效能变量(对广泛的积极变化的强烈期望)以及更广泛的个人支持变量是最好的预测因子。对于高压力患者来说,最好的预测因素包括:存在困扰的亲密关系、缺乏对个人健康问题的关注、有吸烟史,以及可能需要服用精神药物。总体而言,研究结果与自决权理论的基本假设有一定的一致性。结论:研究结果进一步支持了干预前变量的研究可以为提高医疗和其他环境中重大生命干预成功的预测准确性提供有用的信息。
{"title":"The Relationship of Pre-Operative Stress Level to Sustained Outcome in Gastric Bypass Surgery","authors":"R. Lanyon, B. Maxwell","doi":"10.4172/2165-7904.1000269","DOIUrl":"https://doi.org/10.4172/2165-7904.1000269","url":null,"abstract":"Purpose: Previous research has shown that pre-operative health status can serve as a moderator in enhancing the accuracy of certain variables for predicting sustained weight loss after gastric bypass surgery. The present study investigated the role of pre-operative stress level as a moderator in identifying useful pre-operative predictors of sustained weight loss. \u0000Materials and Methods: Follow-up data at a mean of 3.2 years post-operatively were available for 111 patients who had undergone pre-operative assessment on 227 variables including four psychological assessment instruments. These measures were studied for their success in predicting sustained weight loss separately for patients who were under low and high pre-operative stress. \u0000Results: As anticipated, several types of variables (support, coping skills, good adjustment, and good cognitive functioning) predicted success for both groups. In addition, for low-stress patients, social drinking and self-efficacy variables (strong expectations of a broad range of positive changes), and a broader range of personal support variables were the best predictors. For high-stress patients, the best predictors included the presence of a troubled intimate relationship, lack of attention to personal health matters, an active history of smoking, and the possible need for psychiatric medication. Overall, the results show some consistency with the basic postulates of selfdetermination theory. \u0000Conclusion: The findings provide further support for the view that the investigation of pre-intervention variables can provide useful information in enhancing the predictive accuracy of the success of major life interventions in medical and other settings.","PeriodicalId":243288,"journal":{"name":"Journal of obesity and weight loss therapy","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122408723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of Life after Postbariatric Abdominoplasty in Females: Interest of Age, Current Weight and Weight Loss 女性减肥后腹部成形术后的生活质量:年龄、当前体重和体重减轻的影响
Pub Date : 2015-08-31 DOI: 10.4172/2165-7904.1000272
M. Modolin, W. Cintra, R. I. Rocha, J. Faintuch, C. Camargo, R. Gemperli
Background: Aiming to analyze whether abdominoplasty might benefit quality of life of postbariatric females with redundant abdominal skin folds beyond the first year, a clinical investigation after 2-4 years was designed. Despite being a reputed and popular procedure after massive weight loss, results are still debated. It was hypothesized that sustained improvements in quality of life, independent of previous anti-obesity gastroplasty, would be demonstrated. Methods: This was a prospective study in a female cohort. Patients (N=22) were submitted to abdominoplasty with the age of 42.7 ± 9.1 years and body mass index/BMI of 27.2 ± 2.7 kg/m2, about five years after bariatric Rouxen- Y gastric bypass. The interview occurred after an additional 32.0 ± 8.2 months. Results: All post abdominoplasty indices of quality of life were benefitted, with emphasis on body contour, sexual activity and dressing. Despite frequent surgical wound complications (40.9%), most were minor and patients had few complaints about their scars. More than 90% would undergo the operation again, or recommend it to a friend. Major weight loss, or low BMI at the time of abdominoplasty, signaled better sexual and dressing scores. Sexual score was more increased in younger participants. Conclusion: This paper suggest that abdominoplasty in ex-obese patients increased quality of life, related to the following domains body contour, mobility, hygiene, dressing, and sexuality.
背景:为了分析腹部成形术是否能改善1年后腹部皮肤褶皱过多的女性减肥后的生活质量,我们设计了一项2-4年后的临床研究。尽管这是一种很受欢迎的减肥方法,但结果仍然存在争议。据推测,生活质量的持续改善,独立于先前的抗肥胖胃成形术,将被证明。方法:这是一项在女性队列中进行的前瞻性研究。22例患者,年龄42.7±9.1岁,体重指数/BMI为27.2±2.7 kg/m2,于减肥Rouxen- Y胃旁路术后5年左右行腹部成形术。随访时间为32.0±8.2个月。结果:术后生活质量各项指标均有改善,以形体、性活动、穿衣等指标为重点。尽管手术伤口并发症频繁(40.9%),但大多数是轻微的,患者很少抱怨他们的疤痕。超过90%的人会再次接受手术,或者向朋友推荐。体重明显减轻,或腹部成形术时身体质量指数较低,表明在性和穿着方面得分较高。年轻参与者的性行为得分更高。结论:腹部成形术提高了肥胖患者的生活质量,这与身体轮廓、活动能力、卫生、穿着和性行为有关。
{"title":"Quality of Life after Postbariatric Abdominoplasty in Females: Interest of Age, Current Weight and Weight Loss","authors":"M. Modolin, W. Cintra, R. I. Rocha, J. Faintuch, C. Camargo, R. Gemperli","doi":"10.4172/2165-7904.1000272","DOIUrl":"https://doi.org/10.4172/2165-7904.1000272","url":null,"abstract":"Background: Aiming to analyze whether abdominoplasty might benefit quality of life of postbariatric females with redundant abdominal skin folds beyond the first year, a clinical investigation after 2-4 years was designed. Despite being a reputed and popular procedure after massive weight loss, results are still debated. It was hypothesized that sustained improvements in quality of life, independent of previous anti-obesity gastroplasty, would be demonstrated. \u0000Methods: This was a prospective study in a female cohort. Patients (N=22) were submitted to abdominoplasty with the age of 42.7 ± 9.1 years and body mass index/BMI of 27.2 ± 2.7 kg/m2, about five years after bariatric Rouxen- Y gastric bypass. The interview occurred after an additional 32.0 ± 8.2 months. \u0000Results: All post abdominoplasty indices of quality of life were benefitted, with emphasis on body contour, sexual activity and dressing. Despite frequent surgical wound complications (40.9%), most were minor and patients had few complaints about their scars. More than 90% would undergo the operation again, or recommend it to a friend. Major weight loss, or low BMI at the time of abdominoplasty, signaled better sexual and dressing scores. Sexual score was more increased in younger participants. \u0000Conclusion: This paper suggest that abdominoplasty in ex-obese patients increased quality of life, related to the following domains body contour, mobility, hygiene, dressing, and sexuality.","PeriodicalId":243288,"journal":{"name":"Journal of obesity and weight loss therapy","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116740129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Weight Gain on Psychotropic Drugs: Has the Obesity Community been PayingAttention? 精神药物导致体重增加:肥胖界注意到了吗?
Pub Date : 2015-08-31 DOI: 10.4172/2165-7904.1000271
J. Wurtman
Weight gain is a well-known side effect of treatment with psychotropic drugs. More than fifty years ago, drugs such as amitriptyline (Elavil) and lithium were known to be associated with substantial increases in weight and despite new generations of psychotropic drugs, this unwelcome side effect has persisted [1-3]. How much weight is gained varies but in general mood stabilizers and antipsychotics drugs cause more substantial weight gain than antidepressants. Two antipsychotics, clozapine (Clozaril) and olanzapine (Zyprexa) are associated with the greatest prevalence of weight gain; up to 31% of patients treated with clozapine and 40% with olanzapine increase their weight during treatment [3]. Some mood stabilizers such as valproate (Depakote) [3] also are associated with a similarly high incidence of weight gain. Mirtazapine (Remeron) and paroxetine (Paxil) are two antidepressants with the greatest weight gain potential among the anti-depressants although except for buproprion (Wellbutrin) weight gain has been reported among all of the other drugs in this category [4].
体重增加是使用精神药物治疗的一个众所周知的副作用。50多年前,阿米替林(Elavil)和锂等药物被认为与体重大幅增加有关,尽管新一代精神药物出现,但这种不受欢迎的副作用仍然存在[1-3]。体重增加的幅度各不相同,但总的来说,情绪稳定剂和抗精神病药物比抗抑郁药更容易导致体重增加。两种抗精神病药物氯氮平(Clozaril)和奥氮平(Zyprexa)与体重增加的患病率最高有关;高达31%的氯氮平患者和40%的奥氮平患者在治疗期间体重增加[3]。一些情绪稳定剂,如丙戊酸酯[3]也与体重增加的发生率相似。米氮平(雷米隆)和帕罗西汀(帕罗西汀)是抗抑郁药中体重增加潜力最大的两种抗抑郁药,尽管除安非他酮(安非他酮)外,在所有同类药物中都有体重增加的报道[4]。
{"title":"Weight Gain on Psychotropic Drugs: Has the Obesity Community been PayingAttention?","authors":"J. Wurtman","doi":"10.4172/2165-7904.1000271","DOIUrl":"https://doi.org/10.4172/2165-7904.1000271","url":null,"abstract":"Weight gain is a well-known side effect of treatment with psychotropic drugs. More than fifty years ago, drugs such as amitriptyline (Elavil) and lithium were known to be associated with substantial increases in weight and despite new generations of psychotropic drugs, this unwelcome side effect has persisted [1-3]. How much weight is gained varies but in general mood stabilizers and antipsychotics drugs cause more substantial weight gain than antidepressants. Two antipsychotics, clozapine (Clozaril) and olanzapine (Zyprexa) are associated with the greatest prevalence of weight gain; up to 31% of patients treated with clozapine and 40% with olanzapine increase their weight during treatment [3]. Some mood stabilizers such as valproate (Depakote) [3] also are associated with a similarly high incidence of weight gain. Mirtazapine (Remeron) and paroxetine (Paxil) are two antidepressants with the greatest weight gain potential among the anti-depressants although except for buproprion (Wellbutrin) weight gain has been reported among all of the other drugs in this category [4].","PeriodicalId":243288,"journal":{"name":"Journal of obesity and weight loss therapy","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129138599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Taste Preference Evaluation: The First Step towards a Successful Weight Loss Strategy 口味偏好评估:成功减肥策略的第一步
Pub Date : 2015-08-31 DOI: 10.4172/2165-7904.1000E117
S. Choi
The famous phrase, “You are what you eat”, reminds us of the important impact of food choice on weight management. Eating and drinking based on food choice is a highly frequent human behavior that is affected by many factors [1]. Consumers report “taste” as one of the most influential factors affecting food choice [2,3]. Taste is the nutritional gatekeeper that determines which foods are chosen and which are rejected, and given the critical role of food intake in weight loss therapy, taste preference is an extremely important factor that needs to be considered to achieve long-term weight loss success. However, inattention to taste preference in weight loss therapy is common, possibly because of the complexity of the causal links between taste preference and food intake. Therefore, the factors that link taste preference and obesity are briefly reviewed in this article, but these factors are not independent of each other.
“你吃什么就是什么”这句名言提醒我们食物选择对体重管理的重要影响。基于食物选择的饮食是一种非常频繁的人类行为,受多种因素的影响[1]。消费者认为“口味”是影响食品选择的最重要因素之一[2,3]。味觉是决定选择哪些食物和拒绝哪些食物的营养看门人,考虑到食物摄入在减肥治疗中的关键作用,味觉偏好是实现长期减肥成功需要考虑的极其重要的因素。然而,在减肥治疗中忽视味觉偏好是很常见的,可能是因为味觉偏好和食物摄入之间的因果关系很复杂。因此,本文简要回顾了将味觉偏好与肥胖联系起来的因素,但这些因素并非相互独立。
{"title":"Taste Preference Evaluation: The First Step towards a Successful Weight Loss Strategy","authors":"S. Choi","doi":"10.4172/2165-7904.1000E117","DOIUrl":"https://doi.org/10.4172/2165-7904.1000E117","url":null,"abstract":"The famous phrase, “You are what you eat”, reminds us of the important impact of food choice on weight management. Eating and drinking based on food choice is a highly frequent human behavior that is affected by many factors [1]. Consumers report “taste” as one of the most influential factors affecting food choice [2,3]. Taste is the nutritional gatekeeper that determines which foods are chosen and which are rejected, and given the critical role of food intake in weight loss therapy, taste preference is an extremely important factor that needs to be considered to achieve long-term weight loss success. However, inattention to taste preference in weight loss therapy is common, possibly because of the complexity of the causal links between taste preference and food intake. Therefore, the factors that link taste preference and obesity are briefly reviewed in this article, but these factors are not independent of each other.","PeriodicalId":243288,"journal":{"name":"Journal of obesity and weight loss therapy","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130960567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Effectiveness of a Partial Meal Replacement Program in Extremely Obese Individuals: A Systematic Retrospective Chart Review of Medifast Weight Control Centers 部分膳食替代方案在极度肥胖个体中的有效性:Medifast体重控制中心的系统回顾性图表回顾
Pub Date : 2015-07-31 DOI: 10.4172/2165-7904.S5-007
J. Kiel, C. Coleman, Andrea H. Mitola, J. Langford, Kevin N. Davis, L. Arterburn
Background: Extreme obesity is associated with elevated risks of morbidities and mortality, and the prevalence of this condition has been rising. Lifestyle interventions are the cornerstone of all treatment options, yet relatively few studies have assessed the effectiveness of commercial programs for attaining clinically meaningful weight loss (≥ 5%) in this population. The purpose of this study was to evaluate the effectiveness of the Medifast 5 & 2 & 2 Plan™ administered along with counseling in obese adults, a majority of whom were extremely obese. Methods: We conducted a systematic retrospective chart review of 62 obese clients from 17 Medifast Weight Control Centers® (MWCCs). Weight, body composition and cardiometabolic risk factor data were abstracted through 24 weeks. Data were recorded electronically, and key data points were independently verified. The primary endpoint was change from baseline body weight at 12 weeks, assessed using Wilcoxon signed rank tests. Results: The population consisted of 57% men, and 82% had a body mass index of ≥ 40 kg/m2. Mean body weight among completers was reduced by 12.9±7.1 kg (-8.6%, n=37) at the 12-week primary endpoint and by 19.3 ± 11.4 kg (12.5%, n=17) at 24 weeks (p 80%, and the meal plan was well-tolerated. Conclusions: The 5 & 2 & 2 Plan used at MWCCs was effective for achieving clinically meaningful weight loss and improving cardiometabolic risk factors in a population of extremely obese individuals. This lifestyle program represents a viable first line approach for meeting treatment goals in extremely obese adults. #NCT0215083.
背景:极度肥胖与发病率和死亡率的风险升高有关,并且这种情况的患病率一直在上升。生活方式干预是所有治疗方案的基础,但相对较少的研究评估了商业方案在这一人群中实现临床有意义的体重减轻(≥5%)的有效性。本研究的目的是评估Medifast 5 & 2 & 2计划™与咨询一起应用于肥胖成人的有效性,其中大多数是极度肥胖。方法:我们对来自17个Medifast体重控制中心®(MWCCs)的62名肥胖患者进行了系统的回顾性图表回顾。在24周内提取体重、体成分和心脏代谢危险因素数据。数据以电子方式记录,关键数据点独立验证。主要终点是12周时基线体重的变化,使用Wilcoxon签名秩检验进行评估。结果:人群中57%为男性,82%体重指数≥40 kg/m2。在12周的主要终点,完成者的平均体重减少了12.9±7.1 kg (-8.6%, n=37),在24周时减少了19.3±11.4 kg (12.5%, n=17) (p = 80%),饮食计划耐受性良好。结论:在mwcc中使用的5 & 2 & 2计划对于实现有临床意义的体重减轻和改善极度肥胖人群的心脏代谢危险因素是有效的。这种生活方式方案代表了实现极度肥胖成人治疗目标的可行的一线方法。# NCT0215083。
{"title":"The Effectiveness of a Partial Meal Replacement Program in Extremely Obese Individuals: A Systematic Retrospective Chart Review of Medifast Weight Control Centers","authors":"J. Kiel, C. Coleman, Andrea H. Mitola, J. Langford, Kevin N. Davis, L. Arterburn","doi":"10.4172/2165-7904.S5-007","DOIUrl":"https://doi.org/10.4172/2165-7904.S5-007","url":null,"abstract":"Background: Extreme obesity is associated with elevated risks of morbidities and mortality, and the prevalence of this condition has been rising. Lifestyle interventions are the cornerstone of all treatment options, yet relatively few studies have assessed the effectiveness of commercial programs for attaining clinically meaningful weight loss (≥ 5%) in this population. The purpose of this study was to evaluate the effectiveness of the Medifast 5 & 2 & 2 Plan™ administered along with counseling in obese adults, a majority of whom were extremely obese. Methods: We conducted a systematic retrospective chart review of 62 obese clients from 17 Medifast Weight Control Centers® (MWCCs). Weight, body composition and cardiometabolic risk factor data were abstracted through 24 weeks. Data were recorded electronically, and key data points were independently verified. The primary endpoint was change from baseline body weight at 12 weeks, assessed using Wilcoxon signed rank tests. Results: The population consisted of 57% men, and 82% had a body mass index of ≥ 40 kg/m2. Mean body weight among completers was reduced by 12.9±7.1 kg (-8.6%, n=37) at the 12-week primary endpoint and by 19.3 ± 11.4 kg (12.5%, n=17) at 24 weeks (p 80%, and the meal plan was well-tolerated. Conclusions: The 5 & 2 & 2 Plan used at MWCCs was effective for achieving clinically meaningful weight loss and improving cardiometabolic risk factors in a population of extremely obese individuals. This lifestyle program represents a viable first line approach for meeting treatment goals in extremely obese adults. #NCT0215083.","PeriodicalId":243288,"journal":{"name":"Journal of obesity and weight loss therapy","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116895720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Weight Loss Interventions and Outcomes: Type 2 Diabetes 减肥干预和结果:2型糖尿病
Pub Date : 2015-07-30 DOI: 10.4172/2165-7904.S5-005
M. Franz
Background: Benefits of moderate weight loss for the prevention of prediabetes and diabetes are well documented; however, the benefits of weight loss interventions in overt type 2 diabetes are controversial. Objective: To summarize the role of weight loss interventions for the prevention of prediabetes and diabetes and to report the association between weight loss interventions in adults with type 2 diabetes resulting in weight loss greater or less than 5% on metabolic outcomes. Results: Weight loss interventions of 5% to 10% decrease risk factors for prediabetes and diabetes. However, in a systematic review and meta-analysis of weight loss interventions in persons with type 2 diabetes, the majority of the weight loss interventions resulted in weight losses less than 5% and had nonsignificant beneficial effects on A1C and other metabolic outcomes. In another systematic review, reduced-energy eating plans implemented by registered dietitian/nutritionists in persons with type 2 diabetes, regardless of weight loss, resulted in improved A1C levels. Conclusion: Nutrition therapy for persons with type 2 diabetes should encourage a reduced-energy healthful eating plan, regular physical activity, education, and continued support as primary treatment strategies.
背景:适度减肥对预防前驱糖尿病和糖尿病的益处已得到充分证明;然而,减肥干预对显性2型糖尿病的益处是有争议的。目的:总结减肥干预在预防糖尿病前期和糖尿病中的作用,并报道体重减轻大于或小于5%的成人2型糖尿病患者的减肥干预与代谢结局的关系。结果:减肥干预可使糖尿病前期和糖尿病的危险因素降低5%至10%。然而,在对2型糖尿病患者减肥干预的系统回顾和荟萃分析中,大多数减肥干预导致的体重减轻不到5%,并且对糖化血红蛋白和其他代谢结果没有显著的有益影响。在另一项系统综述中,注册营养师/营养学家对2型糖尿病患者实施的低能量饮食计划,无论体重减轻与否,都能改善A1C水平。结论:2型糖尿病患者的营养治疗应鼓励低能量健康饮食计划、定期体育活动、教育和持续支持作为主要治疗策略。
{"title":"Weight Loss Interventions and Outcomes: Type 2 Diabetes","authors":"M. Franz","doi":"10.4172/2165-7904.S5-005","DOIUrl":"https://doi.org/10.4172/2165-7904.S5-005","url":null,"abstract":"Background: Benefits of moderate weight loss for the prevention of prediabetes and diabetes are well documented; however, the benefits of weight loss interventions in overt type 2 diabetes are controversial. \u0000Objective: To summarize the role of weight loss interventions for the prevention of prediabetes and diabetes and to report the association between weight loss interventions in adults with type 2 diabetes resulting in weight loss greater or less than 5% on metabolic outcomes. \u0000Results: Weight loss interventions of 5% to 10% decrease risk factors for prediabetes and diabetes. However, in a systematic review and meta-analysis of weight loss interventions in persons with type 2 diabetes, the majority of the weight loss interventions resulted in weight losses less than 5% and had nonsignificant beneficial effects on A1C and other metabolic outcomes. In another systematic review, reduced-energy eating plans implemented by registered dietitian/nutritionists in persons with type 2 diabetes, regardless of weight loss, resulted in improved A1C levels. \u0000Conclusion: Nutrition therapy for persons with type 2 diabetes should encourage a reduced-energy healthful eating plan, regular physical activity, education, and continued support as primary treatment strategies.","PeriodicalId":243288,"journal":{"name":"Journal of obesity and weight loss therapy","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125804826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Indirect Calorimetry: From Expired CO2 Production, Inspired O2 Consumptionto Energy Equivalent 间接量热法:从过期的二氧化碳生产,激发的氧气消耗到能量当量
Pub Date : 2015-07-30 DOI: 10.4172/2165-7904.S5-001
P. Fassini, Jose Henrique Silvah, C. M. Lima, C. F. Brandão, L. Wichert-Ana, J. Marchini, V. Suen
This paper emphasizes the methodology of data collection of indirect calorimetry, including establishment of steady state conditions and the standards in which the values are presented. It also aims to describe in details the calculations of VO2, VCO2, Resting Energy Expenditure (REE) and Respiratory Quotient (RQ). The trial is registered with ClinicalTrials.gov number NCT02072694.
本文着重介绍了间接量热法数据采集的方法,包括稳态条件的建立和数值呈现的标准。它还旨在详细描述VO2, VCO2,静息能量消耗(REE)和呼吸商(RQ)的计算。该试验已在ClinicalTrials.gov注册,注册号为NCT02072694。
{"title":"Indirect Calorimetry: From Expired CO2 Production, Inspired O2 Consumptionto Energy Equivalent","authors":"P. Fassini, Jose Henrique Silvah, C. M. Lima, C. F. Brandão, L. Wichert-Ana, J. Marchini, V. Suen","doi":"10.4172/2165-7904.S5-001","DOIUrl":"https://doi.org/10.4172/2165-7904.S5-001","url":null,"abstract":"This paper emphasizes the methodology of data collection of indirect calorimetry, including establishment of steady state conditions and the standards in which the values are presented. It also aims to describe in details the calculations of VO2, VCO2, Resting Energy Expenditure (REE) and Respiratory Quotient (RQ). The trial is registered with ClinicalTrials.gov number NCT02072694.","PeriodicalId":243288,"journal":{"name":"Journal of obesity and weight loss therapy","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114222967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Laparoscopic Sleeve Gastrectomy: One Institution's Experience with Omentopexy in the Prevention of Gastric Leaks (Retrospective Review) 腹腔镜袖式胃切除术:某机构网膜固定术预防胃漏的经验(回顾性回顾)
Pub Date : 2015-07-30 DOI: 10.4172/2165-7904.S5-006
P. Hanna, Ricardo Mohammed, M. Nijjar, F. Vazquez, M. Connolly, Jamshed Zuberi
Background: The omentum is associated with accelerated wound healing properties. This IRB-approved multisurgeon single-center study is aimed to evaluate whether complications are reduced by omentopexy (OP) to the staple line after a laparoscopic sleeve gastrectomy. Methods: Adults who have undergone a laparoscopic sleeve gastrectomy at St. Joseph’s Regional Medical Center were reviewed. The group which had the OP performed was compared to the group which did not. Controls were matched for concurrent hiatal hernia repair, degree of obesity, and operating surgeon. OP was only performed by a single surgeon (Surgeon A), however several surgeons performed laparoscopic sleeve gastrectomies. Data extracted included demographics, indication, diagnostic investigations, treatments given, perioperative outcomes, findings, response to treatment given and survival. Complications were defined as a definitive leak or abscess seen on CT or upper GI study. Results: A total of 181 patients underwent a laparoscopic sleeve gastrectomy, of which 75 patients (41%) also underwent OP. 18 patients (9.9%) had a concurrent hiatal hernia repair. Complications were found in 5 patients (2.76%). 4 of the 5 patients who had a complication had underwent OP. Complication rates between the group which had OP and the group which did not have OP showed an OR 6.0571, 95% CI 0.6631 to 55.3280, P 0.1105. No complications were observed in patients who had a concurrent hiatal hernia repair. An association was observed between Surgeon A and increased complications in patients who underwent OP (OR 5.0979, 95% CI 0.2676 to 97.1194, P 0.2787) as well as those who did not undergo OP (OR 1.8271, 95% CI 0.0727 to 45.9307, P 0.7141). An association was also seen between complications and patients who are super obese (OR 1.0833, 95% CI 0.1172 to 10.0126, P 0.9438) and severely obese (OR 2.2319, 95% CI 0.3378 to 14.5153, P 0.3603). No association was seen between complications and patients who are morbidly obese (OR 0.4950, 95% CI 0.0807 to 3.0371, P 0.4474). Limitations: Small sample size, limited patient population, complication rates of a single surgeon performing the omentopexies, comorbidities, as well as limitations of retrospective analysis. Conclusion: OP to the staple line is not associated with decreased overall complication rates. Concurrent hiatal hernia repair was not associated with complications. OP performed in patients who are super obese or severely obese had more complications as opposed to morbidly obese patients who had decreased complications. In addition, OP may be associated with decreased complications only in patients who are morbidly obese. In conclusion, one cannot, in good conscience, continue performing omentopexy given the significantly higher complication rate noted.
背景:大网膜与加速伤口愈合有关。这项经irb批准的多外科医生单中心研究旨在评估腹腔镜袖胃切除术后网膜固定术(OP)是否能减少并发症。方法:对在圣约瑟夫地区医疗中心接受腹腔镜袖胃切除术的成人进行回顾性分析。进行手术的组与未进行手术的组进行比较。对照组在同时进行裂孔疝修补、肥胖程度和手术医生方面进行匹配。OP仅由一名外科医生(外科医生a)实施,但多名外科医生实施了腹腔镜袖胃切除术。提取的数据包括人口统计学、指征、诊断调查、给予的治疗、围手术期结果、发现、对给予的治疗的反应和生存率。并发症的定义是在CT或上消化道检查中发现明确的渗漏或脓肿。结果:共有181例患者行腹腔镜袖胃切除术,其中75例患者(41%)同时行op, 18例患者(9.9%)同时行裂孔疝修补术。并发症5例(2.76%)。有并发症的5例患者中有4例进行了手术。手术组与未手术组的并发症发生率比较,OR为6.0571,95% CI为0.6631 ~ 55.3280,P为0.1105。同时行裂孔疝修补术的患者未见并发症。在手术患者(OR 5.0979, 95% CI 0.2676 ~ 97.1194, P 0.2787)和未手术患者(OR 1.8271, 95% CI 0.0727 ~ 45.9307, P 0.7141)中观察到外科医生A与并发症增加之间的关联。并发症与超级肥胖(OR 1.0833, 95% CI 0.1172 ~ 10.0126, P 0.9438)和严重肥胖(OR 2.2319, 95% CI 0.3378 ~ 14.5153, P 0.3603)患者之间也存在关联。并发症与病态肥胖患者之间无关联(OR 0.4950, 95% CI 0.0807 ~ 3.0371, P 0.4474)。局限性:样本量小,患者人数有限,单个外科医生进行网膜切除术的并发症发生率,合并症,以及回顾性分析的局限性。结论:钉线手术与降低总并发症发生率无关。裂孔疝修补术无并发症。与并发症较少的病态肥胖患者相比,超级肥胖或严重肥胖患者的手术并发症更多。此外,OP可能仅与病态肥胖患者的并发症减少有关。总之,考虑到明显较高的并发症发生率,良心上不能继续进行网膜固定术。
{"title":"Laparoscopic Sleeve Gastrectomy: One Institution's Experience with Omentopexy in the Prevention of Gastric Leaks (Retrospective Review)","authors":"P. Hanna, Ricardo Mohammed, M. Nijjar, F. Vazquez, M. Connolly, Jamshed Zuberi","doi":"10.4172/2165-7904.S5-006","DOIUrl":"https://doi.org/10.4172/2165-7904.S5-006","url":null,"abstract":"Background: The omentum is associated with accelerated wound healing properties. This IRB-approved multisurgeon single-center study is aimed to evaluate whether complications are reduced by omentopexy (OP) to the staple line after a laparoscopic sleeve gastrectomy. \u0000Methods: Adults who have undergone a laparoscopic sleeve gastrectomy at St. Joseph’s Regional Medical Center were reviewed. The group which had the OP performed was compared to the group which did not. Controls were matched for concurrent hiatal hernia repair, degree of obesity, and operating surgeon. OP was only performed by a single surgeon (Surgeon A), however several surgeons performed laparoscopic sleeve gastrectomies. Data extracted included demographics, indication, diagnostic investigations, treatments given, perioperative outcomes, findings, response to treatment given and survival. Complications were defined as a definitive leak or abscess seen on CT or upper GI study. \u0000Results: A total of 181 patients underwent a laparoscopic sleeve gastrectomy, of which 75 patients (41%) also underwent OP. 18 patients (9.9%) had a concurrent hiatal hernia repair. Complications were found in 5 patients (2.76%). 4 of the 5 patients who had a complication had underwent OP. Complication rates between the group which had OP and the group which did not have OP showed an OR 6.0571, 95% CI 0.6631 to 55.3280, P 0.1105. No complications were observed in patients who had a concurrent hiatal hernia repair. An association was observed between Surgeon A and increased complications in patients who underwent OP (OR 5.0979, 95% CI 0.2676 to 97.1194, P 0.2787) as well as those who did not undergo OP (OR 1.8271, 95% CI 0.0727 to 45.9307, P 0.7141). An association was also seen between complications and patients who are super obese (OR 1.0833, 95% CI 0.1172 to 10.0126, P 0.9438) and severely obese (OR 2.2319, 95% CI 0.3378 to 14.5153, P 0.3603). No association was seen between complications and patients who are morbidly obese (OR 0.4950, 95% CI 0.0807 to 3.0371, P 0.4474). \u0000Limitations: Small sample size, limited patient population, complication rates of a single surgeon performing the omentopexies, comorbidities, as well as limitations of retrospective analysis. \u0000Conclusion: OP to the staple line is not associated with decreased overall complication rates. Concurrent hiatal hernia repair was not associated with complications. OP performed in patients who are super obese or severely obese had more complications as opposed to morbidly obese patients who had decreased complications. In addition, OP may be associated with decreased complications only in patients who are morbidly obese. In conclusion, one cannot, in good conscience, continue performing omentopexy given the significantly higher complication rate noted.","PeriodicalId":243288,"journal":{"name":"Journal of obesity and weight loss therapy","volume":"73 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132562966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
Journal of obesity and weight loss therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1